Balaxi Pharmaceuticals Ltd.

₹25.14

0.9 (3.5%)

BALAXI Share Price

Pharmaceuticals & Biotechnology

As on January 28, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 138 Cr

P/E Ratio38.54

Dividend YieldN/A

Trendline Performance

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	24.42	Bullish
10-DMA	24.71	Bullish
20-DMA	25.81	Bearish
50-DMA	30.11	Bearish
100-DMA	36.78	Bearish
200-DMA	44.31	Bearish

Historical Performance

1 Year

-62.7%

3 Years

-77.3%

5 Years

-77.2%

10 Years

437.2%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Net Sales	2,926	2,413	3,364	2,794	2,313
Total Expenditure	2,603	1,968	2,790	2,286	1,887
Other Income	24	6	26	50	22
Operating Profit	346	452	601	558	449
Interest	40	28	14	8	3
Depreciation	19	21	18	5	3
Profit Before Tax	287	20	569	545	443
Consolidated Net Profit	277	-73	517	482	372
Adjusted EPS	5	-1	10	10	7

Compounded Sales Growth

10 Years:245.6

5 Years:6

3 Years:-9.6

TTM:-2.8

Compounded Profit Growth

10 Years:103.8

5 Years:-11.1

3 Years:-24.5

TTM:-0.3

Stock Price CAGR

10 Years:18

5 Years:-24.9

3 Years:-39

TTM:-63.6

Return on Equity

10 Years:-0.1

5 Years:3

3 Years:3.2

last year:0.7

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	110	109	102	100	100
Total Reserves	2,207	1,867	1,624	1,032	550
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	241	28	37	---	---
Other Current Liabilities	46	46	28	33	1
Short Term Borrowings	304	177	108	36	37
Total Liabilities	3,103	2,583	2,397	1,765	997
Capital Work in Progress	221	23	28	6	---
Long Term Loans & Advances	40	46	15	13	---
Currents Investments	---	---	---	---	---
Short Term Loans and Advances	119	80	42	37	10
Total Current Assets	2,428	2,102	1,935	1,410	938
Total Assets	3,103	2,583	2,397	1,765	997
Adjusted Book Value	42	36	34	113	65

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 38.54, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a weak 3-year price CAGR of -38.1%, indicating poor shareholder returns.
The stock carries a beta of 0.8, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹80 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹610 million, indicating a relatively small business scale.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 364242.2

No. of Shares: 14489 (Approx)

Performance:-63.6%

P/L: ₹-635757.8

NIFTY Performance: 9.4%

1 day Top Gainers